NEW YORK (GenomeWeb) ­– Sequencing platform developer ReadCoor has been awarded a $2.5 million, two-year grant from the Bill and Melinda Gates Foundation to develop the infectious disease detection capabilities of its tissue-based fluorescent in situ sequencing (FISSEQ ) technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.